Liquid biopsy identifies tumor-derived mir-302/367 cluster as a macrophage-reprogramming axis sustaining immune cold prostate cancer
Despite extensive clinical investigation, immunotherapy has failed to demonstrate consistent clinical benefit in prostate cancer (PCa), largely due to the development of an immunologically cold tumor microenvironment that resists immunotherapeutic strategies. However, the mechanisms through which systemic signals...